Ariella B Hanker Selected Research

Ariella B Hanker Research Topics

Disease

23	Neoplasms (Cancer) 04/2024 - 01/2008
23	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2008
3	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 04/2024
1	Triple Negative Breast Neoplasms 01/2022
1	Bites and Stings (Sting) 01/2022
1	Carcinogenesis 12/2017
1	Pathologic Complete Response 08/2017
1	Disease Progression 01/2017
1	Hypoxia (Hypoxemia) 12/2016

Drug/Important Bio-Agent (IBA)

6	Trastuzumab (Herceptin)FDA Link 02/2023 - 08/2013
6	neratinibIBA 01/2023 - 01/2017
6	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2017
5	Estrogen ReceptorsIBA 03/2024 - 12/2016
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2015
4	Estrogens (Estrogen)FDA Link 01/2021 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 02/2023 - 08/2009
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 12/2016
3	Phosphotransferases (Kinase)IBA 01/2023 - 12/2017
3	ErbB Receptors (EGF Receptor)IBA 12/2017 - 07/2015
2	Phenobarbital (Luminal)FDA Link 04/2024 - 08/2013
2	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 03/2024 - 07/2023
2	Fulvestrant (Faslodex)FDA Link 07/2023 - 01/2023
2	Docetaxel (Taxotere)FDA Link 02/2023 - 01/2023
2	Therapeutic UsesIBA 02/2023 - 01/2023
2	plerixafor FDA Link 02/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2017
2	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2021 - 10/2020
2	Mechanistic Target of Rapamycin Complex 1IBA 10/2020 - 02/2020
2	IntegrinsIBA 02/2019 - 01/2017
2	Lapatinib (GW572016)FDA Link 08/2017 - 08/2013
2	Drug CombinationsIBA 08/2017 - 01/2017
2	pertuzumabIBA 01/2017 - 08/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016 - 01/2016
1	PlasticsIBA 04/2024
1	A-Form DNA (A-DNA)IBA 01/2024
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2024
1	Neurofibromin 1 (Neurofibromin)IBA 01/2023
1	binimetinibIBA 01/2023
1	Dynamins (Dynamin)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	InterferonsIBA 01/2022
1	ChemokinesIBA 01/2022
1	erdafitinibIBA 01/2021
1	Letrozole (Femara)FDA LinkGeneric 01/2021
1	ChromatinIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Proline (L-Proline)FDA Link 10/2020
1	Circulating Tumor DNAIBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	palbociclibIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 12/2017
1	tributyl phosphate (TBP)IBA 01/2017
1	CollagenIBA 01/2017
1	AntibodiesIBA 01/2017
1	Cell-Free Nucleic AcidsIBA 01/2017
1	NVP-BKM120IBA 01/2017
1	Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA 12/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2016
1	ProteomeIBA 12/2016
1	Messenger RNA (mRNA)IBA 12/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2015
1	human ERBB2 proteinIBA 08/2013
1	ClaudinsIBA 08/2013
1	romidepsin (FK228)FDA Link 08/2009
1	Histone Deacetylase InhibitorsIBA 08/2009
1	Histones (Histone)IBA 08/2009
1	Monomeric GTP-Binding ProteinsIBA 01/2008
1	Guanosine Triphosphate (GTP)IBA 01/2008
1	Growth InhibitorsIBA 01/2008
1	Estrogen Receptor alphaIBA 01/2008

Therapy/Procedure

12	Therapeutics 04/2024 - 08/2013
1	Drug Therapy (Chemotherapy) 10/2015
1	Neoadjuvant Therapy 10/2015